Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause. Two phase 3 clinical trials compared the drug ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Fezolinetant (Veozah), the first of a new class of non-hormonal ... and Drug Administration in 2023 for the treatment of moderate to severe hot flashes. This class of drugs targets a specific ...

Recent studies are helping researchers better understand the power of the mind-body connection in treating hot flashes.

"Last year, the FDA approved a new type of medication for the treatment of moderate to severe hot flashes called fezolinetant (brand name Veozah)," adds Nonacs. Minkin says that herbal remedies ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...